ACTAVIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Mar 2025)
What this means for you
Registered since 16 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85773894
- Registration number
- 5586410
- Mark type
- Design + words
- Filed
- 07 Nov 2012
- Published for opposition
- 06 Aug 2013
- Registered
- 16 Oct 2018
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of alimentary tract diseases and disorders, musculo-skeletal system diseases and disorders, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations and substances for the treatment of fluctuating hormone levels
Owner
- ACTAVIS HOLDCO US, INC., PARSIPPANY, NJ, US
- ACTAVIS HOLDCO US, INC., PARSIPPANY, NJ, US
- ACTAVIS, INC., PARSIPPANY, NJ, US
- ACTAVIS, INC., PARSIPPANY, NJ, US
- Actavis Group PTC ehf, Hafnarfjordur, IS
Prosecution history
- 04 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Oct 2024 — TEAS SECTION 8 & 15 RECEIVED
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 08 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Sept 2018 — USE AMENDMENT FILED
- 05 Sept 2018 — TEAS STATEMENT OF USE RECEIVED
- 14 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2018 — SOU EXTENSION 5 GRANTED
- 08 Mar 2018 — SOU EXTENSION 5 FILED
- 08 Mar 2018 — SOU TEAS EXTENSION RECEIVED